Insight Capital Research & Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Insight Capital Research & Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$2.7M	Sell	35,389 -2,608	-7%	-$197K	1.52%	17
2017 Q2	$2.85M	Sell	37,997 -12,020	-24%	-$833K	1.67%	13
2017 Q1	$3.26M	Sell	50,017 -1,546	-3%	-$91.1K	1.83%	17
2016 Q4	$2.84M	Buy	+51,563	New	+$2.83M	1.51%	18
2016 Q3	–	Sell	-62,387	Closed	-$2.6M	–	138
2016 Q2	$2.6M	Buy	+62,387	New	+$2.87M	0.91%	60

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Insight Capital Research & Management's PRAH Position: Q3 2017 in Review

Insight Capital Research & Management reduced its PRA Health Sciences, Inc. (PRAH) stake by 6.9% in Q3 2017, selling an estimated $197K and leaving 35,389 shares worth $2.7M. The position accounts for 1.52% of the portfolio, ranked #17.

Insight Capital Research & Management first reported a position in PRAH in Q2 2016 and has held it in 5 quarters since. The position peaked at $3.26M in Q1 2017. 261 funds tracked by Wall St. Rank hold PRAH as of Q3 2017.

Insight Capital Research & Management held 35,389 shares of PRA Health Sciences, Inc. worth $2.7M as of Q3 2017.
Insight Capital Research & Management sold 2,608 PRA Health Sciences, Inc. shares in Q3 2017, an estimated $197K.
PRA Health Sciences, Inc. made up 1.52% of Insight Capital Research & Management's portfolio in Q3 2017, its #17 holding.
Insight Capital Research & Management first reported a position in PRA Health Sciences, Inc. in Q2 2016 and has held it in 5 quarters since.
Insight Capital Research & Management's PRA Health Sciences, Inc. position peaked at $3.26M in Q1 2017.
261 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.